Trial Profile
High-dose olmesartan medoxomil + indapamide vs standard-dose olmesartan medoxomil + amlodipine + indapamide in diabetic patients with hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 May 2012
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Indapamide (Primary) ; Olmesartan medoxomil (Primary)
- Indications Hypertension in diabetes
- Focus Therapeutic Use
- 15 May 2012 New trial record
- 29 Apr 2012 Results presented at the 22nd European Meeting on Hypertension.